AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder

Journal of Affective Disorders

Volumn 136, Issue 3, 2012, Pages 1232-1237

  Gibbons, Andrew Stuart ^a,b   Brooks, Lucy ^a,b,c   Scarr, Elizabeth ^a,b   Dean, Brian ^a,b,d  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

Author keywords

AMPA receptor; Bipolar disorder frontal cortex; Kainate receptor; Major depressive disorder

Indexed keywords

AMPA RECEPTOR; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; KAINIC ACID RECEPTOR; MIRTAZAPINE; NORTRIPTYLINE; RADIOLIGAND; SERTRALINE; VENLAFAXINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ADULT; AGED; BIPOLAR DISORDER; CADAVER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; POSTMORTEM CHANGES; PREFRONTAL CORTEX; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84857355587     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.10.001     Document Type: Article

References (35)

1. D.P. Auer, B. Putz, E. Kraft, B. Lipinski, J. Schill, and F. Holsboer Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study Biological Psychiatry 47 2000 305 313
2. C.J. Bench, K.J. Friston, R.G. Brown, L.C. Scott, R.S.J. Frackowiak, and R.J. Dolan The anatomy of melancholia-focal abnormalities of cerebral blood-flow in major depression Psychological Medicine 22 1992 607 615
3. M. Beneyto, L.V. Kristiansen, A. Oni-Orisan, R.E. McCullumsmith, and J.H. Meador-Woodruff Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders Neuropsychopharmacology 32 2007 1888 1902
4. P.V. Choudary, M. Molnar, S.J. Evans, H. Tomita, J.Z. Li, M.P. Vawter, R.M. Myers, W.E. Bunney Jr.; H. Akil, S.J. Watson, and E.G. Jones Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression Proceedings of the National Academy of Sciences of the United States of America 102 2005 15653 15658
5. S. Chourbaji, M.A. Vogt, F. Fumagalli, R. Sohr, A. Frasca, C. Brandwein, H. Hortnagl, M.A. Riva, R. Sprengel, and P. Gass AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression The FASEB Journal 22 2008 3129 3134
6. B. Dean, G. Pavey, M. McLeod, K. Opeskin, N. Keks, and D. Copolov A change in the density of [H-3]flumazenil, but not [H-3]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder Journal of Affective Disorders 66 2001 147 158
7. A.M. Feyissa, A. Chandran, C.A. Stockmeier, and B. Karolewicz Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression Progress in Neuro-psychopharmacology & Biological Psychiatry 33 2009 70 75
8. A.M. Feyissa, W.L. Woolverton, J.J. Miguel-Hidalgo, Z.X. Wang, P.B. Kyle, G. Hasler, C.A. Stockmeier, A.H. Iyo, and B. Karolewicz Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression Progress in Neuro-psychopharmacology & Biological Psychiatry 34 2010 279 283
9. J.A. Gliner, G.A. Morgan, and R.J. Harmon Basic associated designs: analysis and interpretation Journal of the American Academy of Child and Adolescent Psychiatry 41 2002 1256 1258
10. K. Hashimoto, A. Sawa, and M. Iyo Increased levels of glutamate in brains from patients with mood disorders Biological Psychiatry 62 2007 1310 1316
11. C. Hill, N. Keks, S. Roberts, K. Opeskin, B. Dean, A. MacKinnon, and D. Copolov Problem of diagnosis in postmortem brain studies of schizophrenia The American Journal of Psychiatry 153 1996 533 537
12. D.C. Javitt Glutamate as a therapeutic target in psychiatric disorders Molecular Psychiatry 9 2004 984 997
13. J.S. Jouhanneau, S.M. Ball, E. Molnar, and J.T.R. Isaac Mechanisms of bi-directional modulation of thalamocortical transmission in barrel cortex by presynaptic kainate receptors Neuropharmacology 60 2011 832 841
14. N. Keks, C. Hill, K. Opeskin, D.L. Copolov, and B. Dean Psychiatric diagnosis after death: the problems of accurate diagnosis B. Dean, T.M. Hyde, J.E. Klienman, Using CNS Tissue in Psychiatry Research: a Practical Guide 1999 J. Gordon & Breach Science Publishers Sydney 19 37
15. R.W. Kerwin, S. Patel, B.S. Meldrum, C. Czudek, and G.P. Reynolds Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia Lancet 1 1988 583 584
16. A.E. Kingsbury, O.J. Foster, A.P. Nisbet, N. Cairns, L. Bray, D.J. Eve, A.J. Lees, and C.D. Marsden Tissue pH as an indicator of mRNA preservation in human post-mortem brain Brain Research. Molecular Brain Research 28 1995 311 318
17. M.B. Knable, E.F. Torrey, M.J. Webster, and J.J. Bartko Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium Brain Research Bulletin 55 2001 651 659
18. X. Li, J.P. Tizzano, K. Griffey, M. Clay, T. Lindstrom, and P. Skolnick Antidepressant-like actions of an AMPA receptor potentiator (LY392098) Neuropharmacology 40 2001 1028 1033
19. X. Li, J.M. Witkin, A.B. Need, and P. Skolnick Enhancement of antidepressant potency by a potentiator of AMPA receptors Cellular and Molecular Neurobiology 23 2003 419 430
20. S. Maeng, C.A. Zarate, J. Du, R.J. Schloesser, J. McCammon, G. Chen, and H.K. Manji Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors Biological Psychiatry 63 2008 349 352
21. R. Martinez-Turrillas, D. Frechilla, and J. Del Rio Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus Neuropharmacology 43 2002 1230 1237
22. M.C. Mauri, A. Ferrara, L. Boscati, S. Bravin, F. Zamberlan, M. Alecci, and G. Invernizzi Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment Neuropsychobiology 37 1998 124 129
23. D.A. McCormick Neurotransmitter actions in the thalamus and cerebral-cortex and their role in neuromodulation of thalamocortical activity Progress in Neurobiology 39 1992 337 388
24. H. Mitani, Y. Shirayama, T. Yamada, K. Maeda, C.R. Ashby, and R. Kawahara Correlation between plasma levels of glutamate, alanine and serine with severity of depression Progress in Neuro-psychopharmacology & Biological Psychiatry 30 2006 1155 1158
25. J.A. O'Connor, E.C. Muly, S.E. Arnold, and S.E. Hemby AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs Schizophrenia Research 90 2007 28 40
26. N. Palomero-Gallagher, B.A. Vogt, A. Schleicher, H.S. Mayberg, and K. Zilles Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model Human Brain Mapping 30 2009 2336 2355
27. R.X.A. Petrie, I.C. Reid, and C.A. Stewart The N-methyl-d-aspartate receptor, synaptic plasticity, and depressive disorder - a critical review Pharmacology and Therapeutics 87 2000 11 25
28. S.B. Roberts, C.A. Hill, B. Dean, N.A. Keks, K. Opeskin, and D.L. Copolov Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience The Australian and New Zealand Journal of Psychiatry 32 1998 73 76
29. E. Scarr, G. Pavey, S. Sundram, A. MacKinnon, and B. Dean Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder Bipolar Disorders 5 2003 257 264
30. E. Scarr, M. Beneyto, J.H. Meador-Woodruff, and B. Dean Cortical glutamatergic markers in schizophrenia Neuropsychopharmacology 30 2005 1521 1531
31. P. Skolnick, P. Popik, and R. Trullas Glutamate-based antidepressants: 20 years on Trends in Pharmacological Sciences 30 2009 563 569
32. J.C. Soares, and J.J. Mann The functional neuroanatomy of mood disorders Journal of Psychiatric Research 31 1997 393 432
33. P. Svenningsson, E.T. Tzavara, J.M. Witkin, A.A. Fienberg, G.G. Nomikos, and P. Greengard Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac) Proceedings of the National Academy of Sciences of the United States of America 99 2002 3182 3187
34. T. Tsumoto Excitatory amino-acid transmitters and their receptors in neural circuits of the cerebral neocortex Neurosciences Research 9 1990 79 102
35. K. Zilles, N. Palomero-Gallagher, and A. Schleicher Transmitter receptors and functional anatomy of the cerebral cortex Journal of Anatomy 205 2004 417 432